Figure 4From: Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology Log-rank analysis of progression-free survival (PFS) and overall survival (OS) for patients with (M) and without (WT) KIT L541 variant in phase II Desminib trial. Back to article page